Maravai LifeSciences (MRVI)
(Delayed Data from NSDQ)
$10.53 USD
+0.07 (0.67%)
Updated May 13, 2024 04:00 PM ET
After-Market: $10.54 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | 0.00 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 33.33% |
ABR | 1.63 |
Earnings ESP
|
700.01% |
---|---|
Current Year | -0.01 |
Next Year | 0.05 |
EPS (TTM) | -0.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 69.10M | 69.44M | 273.58M | 296.24M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 72.60M | 71.38M | 275.20M | 307.10M |
Low Estimate | 67.45M | 67.40M | 268.91M | 290.78M |
Year ago Sales | 68.91M | 66.87M | 288.95M | 273.58M |
Year over Year Growth Est. | 0.28% | 3.85% | -5.32% | 8.29% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.00 | 0.00 | -0.01 | 0.05 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.00 | 0.01 | 0.02 | 0.06 |
High Estimate | 0.02 | 0.01 | 0.04 | 0.08 |
Low Estimate | -0.01 | -0.01 | -0.03 | 0.02 |
Year ago EPS | 0.00 | -0.01 | 0.03 | -0.01 |
Year over Year Growth Est. | NA | 100.00% | -133.33% | 500.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.00 | 0.00 | -0.01 | 0.05 |
7 Days Ago | -0.01 | 0.00 | -0.01 | 0.05 |
30 Days Ago | -0.01 | 0.00 | -0.01 | 0.05 |
60 Days Ago | -0.01 | 0.00 | -0.01 | 0.05 |
90 Days Ago | -0.01 | 0.00 | 0.03 | 0.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | 0.00 | 0.04 | 0.08 |
Zacks Consensus Estimate | 0.00 | 0.00 | -0.01 | 0.05 |
Earnings ESP | 700.01% | 0.00% | 900.00% | 77.78% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | 0.01 | -0.01 | 0.00 | NA |
Estimate | -0.03 | -0.01 | 0.00 | 0.01 | NA |
Difference | 0.01 | 0.02 | -0.01 | -0.01 | 0.00 |
Surprise | 33.33% | 200.00% | NA | -100.00% | 44.44% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more